Teladoc’s competitive advantage has been strengthening over the years, and the strategic merger with Livongo has only extended their lead further ahead.

Teladoc has now reached value stock status but yet is still capable of producing 15-20% growth. Find out if you should add TDOC to your portfolio.

Teladoc Health › Just because a stock has been battered doesn't make it an automatic buy. That's only the case if it can bounce back, and in some cases, there are few good reasons to believe it can.

Teladoc Health, Inc. (TDOC) is a leading global virtual healthcare services provider, connecting patients and physicians in the United States and internationally. Today, the company facilitates ...

Digital medical services platform Teladoc Health (NYSE:TDOC) will be reporting results this Tuesday after market close. Here’s what investors should know.

Teladoc Health has released new data from two studies presented at the American Diabetes Association's 84th Scientific Sessions. The studies show that Teladoc's predictive modeling capabilities ...

The market is lumping Teladoc into a crowded and competitive telehealth field. The market is wrong. Teladoc is building an end-to-end virtual care stack that differentiates it from other ...

Shares of struggling telehealth company Teladoc Health (NYSE: TDOC) collapsed after it recently released earnings for the first quarter of 2022. After shooting to roughly $300 per share in early ...

AI, M&A and MSK: Teladoc’s head of group health shares vendor’s strategic priorities Kelly Bliss shared her thoughts on how the virtual care giant is approaching the three buzzy acronyms in an ...

Teladoc stubbed its toe when it overpaid to buy Livongo in 2020. On a positive note, the user base is growing, and write-offs are mainly over. But weak financials continue to make Teladoc a ...

Teladoc (NYSE: TDOC) stock is on the move today as investors in the telemedicine company react to news of Amazon (NASDAQ: AMZN) acquiring One Medical(NASDAQ:ONEM).